Ultra-low-dose estradiol and norethisterone acetate: effective menopausal symptom relief (Q39336361)

11 September 2017

title

Ultra-low-dose estradiol and norethisterone acetate: effective menopausal symptom relief (English)

1 reference

11 September 2017

Panay N

1

1 reference

11 September 2017

Ylikorkala O

2

1 reference

11 September 2017

Archer DF

3

1 reference

11 September 2017

Gut R

4

1 reference

11 September 2017

Lang E

5

1 reference

11 September 2017

publication date

1 April 2007

1 reference

11 September 2017

1 reference

11 September 2017

volume

10

1 reference

11 September 2017

issue

2

1 reference

11 September 2017

page(s)

120-131

1 reference

Practical recommendations for hormone replacement therapy in the peri- and postmenopause

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1080/13697130701298107

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13697130701298107

Risk of hospital admission for idiopathic venous thromboembolism among users of postmenopausal oestrogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13697130701298107

A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13697130701298107

Initial 17beta-estradiol dose for treating vasomotor symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13697130701298107

Constructing a standard climacteric scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13697130701298107

Uterine bleeding in postmenopausal women on continuous therapy with estradiol and norethindrone acetate. Endometrium Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13697130701298107

Efficacy and local tolerance of a low-dose, 7-day matrix estradiol transdermal system in the treatment of menopausal vasomotor symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13697130701298107

Endometrial effects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate: two-year substudy results

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13697130701298107

Relief of vasomotor symptoms and vaginal atrophy with lower doses of conjugated equine estrogens and medroxyprogesterone acetate

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13697130701298107

Dose-ranging studies of a novel intranasal estrogen replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13697130701298107

Effects of low-dose, continuous combined estradiol and noretisterone acetate on menopausal quality of life in early postmenopausal women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13697130701298107

Effects of low-dose, continuous combined hormone replacement therapy on sleep in symptomatic postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13697130701298107

Progestogen intolerance and compliance with hormone replacement therapy in menopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13697130701298107

10.1080/13697130701298107

21 January 2018

Identifiers

DOI

1 reference

11 September 2017

1 reference